All Stories

  1. Survival gain analysis: Immunotherapy versus bevacizumab and irinotecan
  2. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma
  3. New perspectives in glioblastoma antiangiogenic therapy
  4. The effect of curcumin on low-passage glioblastoma cells in vitro
  5. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker
  6. Helianthin induces antiproliferative effect on human glioblastoma cells in vitro
  7. Growth factor receptors signaling in glioblastoma cells: therapeutic implications
  8. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells
  9. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell linesin vitro